Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Medtronic Eyes Up to $350M Tariff Hit in FY26, Leans On Cost Controls And Pricing Strategy
Higher Interest, Tax And Simplera Scale-Up Costs Compress Margins And EPS Growth.
May 27 2025
•
By
Shubham Singh
Medtronic’s strategy to absorb tariff costs includes scaling its cost-of-goods-sold (COGS) efficiency programs and enforcing pricing discipline
(Shutterstock)
More from Strategy
More from Medtech Insight